World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
24122
World Ranking
3662
National Ranking
1691

Nadine Rouphael publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nadine Rouphael sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 294 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nadine Rouphael D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nadine Rouphael sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nadine Rouphael is affiliated with Emory University in the United States and has made extensive contributions to the field of medicine, particularly focusing on infectious diseases, epidemiology, and immunology. Their research portfolio includes studies on SARS-CoV-2 and COVID-19, COVID-19 clinical research studies, influenza virus investigations, respiratory viral infections, and immunotherapy applications.

The scientist has published numerous papers, with notable recent works including:

  • "An mRNA Vaccine against SARS-CoV-2 - Preliminary Report" (2020) published in the New England Journal of Medicine
  • "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19" (2020) published in the New England Journal of Medicine
  • "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults" (2020) published in the New England Journal of Medicine
  • "Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans" (2020) published in Science
  • "The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients" (2020) published in Science Immunology

Rouphael's frequent coauthors include Evan J. Anderson, Lindsey R. Baden, Mark J. Mulligan, Christina A. Rostad, and Lilin Lai, indicating collaboration with researchers engaged in similar fields of study.

Their research is disseminated through multiple publication venues, with the most frequent being:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • Vaccines
  • Clinical Infectious Diseases

Main fields of study encompassed by their work include Medicine with a focus on subfields such as:

  • Infectious Diseases
  • Epidemiology
  • Immunology
  • Molecular Biology
  • Neurology

Prominent research topics addressed by Rouphael comprise:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • SARS-CoV-2 detection and testing
  • Respiratory viral infections research
  • Long-Term Effects of COVID-19
  • Immunotherapy and Immune Responses

Best Publications

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.

    Prabhu S. Arunachalam;Florian Wimmers;Chris Ka Pun Mok;Ranawaka A. P. M. Perera

  • The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

    Lakshmanane Premkumar;Bruno Segovia-Chumbez;Ramesh Jadi;David R. Martinez

  • Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

    Shuzhao Li;Nadine Rouphael;Sai Duraisingham;Sandra Romero-Steiner

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Infections associated with haemophagocytic syndrome

    Nadine G Rouphael;Naasha J Talati;Camille Vaughan;Kelly Cunningham

  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

    Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

  • Rapid generation of neutralizing antibody responses in COVID-19 patients

    Mehul S. Suthar;Mehul S. Suthar;Matthew G. Zimmerman;Matthew G. Zimmerman;Robert C. Kauffman;Grace Mantus

  • Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.

    Thomas Hagan;Mario Cortese;Nadine Rouphael;Carolyn Boudreau

  • Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

    Pegu, Amarendra, O’Connell, Sarah E.;Stephen D. Schmidt;O’Dell, Sijy, Talana, Chloe A.

  • Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.

    Kristen W. Cohen;Susanne L. Linderman;Zoe Moodie;Julie Czartoski

  • The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

    Nadine G Rouphael;Michele Paine;Regina Mosley;Sebastien Henry

  • Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

    Unknown

  • Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

    Helder I. Nakaya;Thomas Hagan;Sai S. Duraisingham;Eva K. Lee

  • Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    Martin R Gaudinski;Katherine V Houser;Kaitlyn M Morabito;Zonghui Hu

  • mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

    Unknown

  • Metabolic Phenotypes of Response to Vaccination in Humans

    Shuzhao Li;Nicole L. Sullivan;Nadine Rouphael;Tianwei Yu

  • Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

    Unknown

  • COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva.

    Nora Pisanic;Pranay R. Randad;Kate Kruczynski;Yukari C. Manabe

  • Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.

    Venkata Viswanadh Edara;Carson Norwood;Katharine Floyd;Katharine Floyd;Lilin Lai;Lilin Lai

Frequent Co-Authors

Mark J. Mulligan
Mark J. Mulligan New York University
Rafi Ahmed
Rafi Ahmed Emory University
Bali Pulendran
Bali Pulendran Stanford University
Mehul S. Suthar
Mehul S. Suthar Emory University
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
David S. Stephens
David S. Stephens Emory University
Wendy A. Keitel
Wendy A. Keitel Baylor College of Medicine
Jens Wrammert
Jens Wrammert Emory University
Sharon E. Frey
Sharon E. Frey Saint Louis University
Monica M. Farley
Monica M. Farley Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career options. Programs like Licensed Practical Nurse (LPN) offer foundational clinical skills and are accessible through many lpn schools easy to get into. These pathways provide essential patient care experience that complements immunology knowledge.

Nursing offers progressive opportunities, especially for those aiming to specialize in patient health. The easiest np program options enable quicker entry into advanced nursing roles, combining clinical expertise with immunological principles for better patient outcomes.

Specializations such as Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs allow students to focus on mental health alongside immunological research. Discover the best programs with strong support through pmhnp programs online with best clinical placement, ensuring hands-on experience in relevant settings.

Cost remains a major consideration for many students. Fortunately, there are cheap psych np programs that balance affordability with quality education, making specialized nursing degrees accessible while paving the way for careers integrating immunology and psychiatric care.

Best Scientists Citing Nadine Rouphael

Trending Scientists

Recently Published Articles